Compare Sterling Biotech with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FDC LTD. - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FDC LTD. STERLING BIOTECH/
FDC LTD.
 
P/E (TTM) x -0.4 16.2 - View Chart
P/BV x 0.0 2.2 0.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   FDC LTD.
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FDC LTD.
Mar-18
STERLING BIOTECH/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs11319 3.3%   
Low Rs3164 2.1%   
Sales per share (Unadj.) Rs26.861.6 43.5%  
Earnings per share (Unadj.) Rs-15.09.9 -150.3%  
Cash flow per share (Unadj.) Rs-5.512.0 -45.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.973.2 75.0%  
Shares outstanding (eoy) m267.87174.40 153.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.33.9 6.6%   
Avg P/E ratio x-0.524.3 -1.9%  
P/CF ratio (eoy) x-1.320.2 -6.3%  
Price / Book Value ratio x0.13.3 3.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86242,118 4.4%   
No. of employees `0001.45.5 24.5%   
Total wages/salary Rs m5472,167 25.2%   
Avg. sales/employee Rs Th5,303.31,943.7 272.8%   
Avg. wages/employee Rs Th403.8391.7 103.1%   
Avg. net profit/employee Rs Th-2,959.0313.7 -943.2%   
INCOME DATA
Net Sales Rs m7,18110,751 66.8%  
Other income Rs m43510 8.4%   
Total revenues Rs m7,22311,260 64.1%   
Gross profit Rs m9472,267 41.8%  
Depreciation Rs m2,543351 723.7%   
Interest Rs m4,37714 31,265.0%   
Profit before tax Rs m-5,9312,411 -246.0%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924671 -286.7%   
Profit after tax Rs m-4,0071,735 -230.9%  
Gross profit margin %13.221.1 62.5%  
Effective tax rate %32.427.8 116.6%   
Net profit margin %-55.816.1 -345.7%  
BALANCE SHEET DATA
Current assets Rs m14,3357,213 198.8%   
Current liabilities Rs m49,8092,104 2,367.7%   
Net working cap to sales %-494.047.5 -1,039.6%  
Current ratio x0.33.4 8.4%  
Inventory Days Days40354 740.3%  
Debtors Days Days17128 615.5%  
Net fixed assets Rs m55,4326,865 807.5%   
Share capital Rs m268175 152.9%   
"Free" reserves Rs m13,93512,586 110.7%   
Net worth Rs m14,70112,761 115.2%   
Long term debt Rs m9,4786 157,964.2%   
Total assets Rs m73,98815,041 491.9%  
Interest coverage x-0.4173.2 -0.2%   
Debt to equity ratio x0.60 137,117.4%  
Sales to assets ratio x0.10.7 13.6%   
Return on assets %0.511.6 4.3%  
Return on equity %-27.313.6 -200.4%  
Return on capital %-6.419.0 -33.9%  
Exports to sales %25.912.3 209.8%   
Imports to sales %0.20-   
Exports (fob) Rs m1,8601,327 140.2%   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8601,889 98.5%   
Fx outflow Rs m250-   
Net fx Rs m1,8351,889 97.1%   
CASH FLOW
From Operations Rs m1,7191,498 114.7%  
From Investments Rs m-3,148201 -1,565.5%  
From Financial Activity Rs m1,426-1,694 -84.2%  
Net Cashflow Rs m-310 -33.0%  

Share Holding

Indian Promoters % 33.9 68.9 49.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 9.9 7.5 132.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 19.0 206.8%  
Shareholders   21,482 23,730 90.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   WOCKHARDT  FULFORD INDIA  PROCTER & GAMBLE HEALTH  BIOCON   UNICHEM LAB  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS